Cibc World Markets Corp Purchases 2,532 Shares of Revvity, Inc. (NYSE:RVTY)

Cibc World Markets Corp increased its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 15.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,304 shares of the company's stock after acquiring an additional 2,532 shares during the period. Cibc World Markets Corp's holdings in Revvity were worth $2,155,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. EdgePoint Investment Group Inc. boosted its position in shares of Revvity by 34.6% during the third quarter. EdgePoint Investment Group Inc. now owns 2,685,775 shares of the company's stock valued at $343,108,000 after buying an additional 690,534 shares during the last quarter. Southpoint Capital Advisors LP purchased a new position in Revvity during the 3rd quarter worth $25,550,000. Proficio Capital Partners LLC grew its stake in shares of Revvity by 12,298.3% in the 4th quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock worth $21,850,000 after acquiring an additional 194,190 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Revvity by 1.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,335,302 shares of the company's stock worth $809,332,000 after acquiring an additional 108,401 shares in the last quarter. Finally, Holocene Advisors LP raised its holdings in shares of Revvity by 14.6% in the third quarter. Holocene Advisors LP now owns 725,917 shares of the company's stock valued at $92,736,000 after purchasing an additional 92,240 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, insider Tajinder S. Vohra sold 5,492 shares of the firm's stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now directly owns 19,652 shares of the company's stock, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Joel S. Goldberg sold 15,170 shares of the firm's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company's stock, valued at $4,232,782. The trade was a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by corporate insiders.

Revvity Price Performance

Shares of RVTY traded up $0.04 during trading hours on Wednesday, reaching $107.42. 806,063 shares of the company's stock traded hands, compared to its average volume of 850,451. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm's 50 day simple moving average is $115.89 and its 200-day simple moving average is $117.42. The stock has a market cap of $12.91 billion, a PE ratio of 48.61, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the business posted $1.25 EPS. Equities analysts expect that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be paid a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.26%. Revvity's dividend payout ratio (DPR) is 12.67%.

Analyst Upgrades and Downgrades

RVTY has been the subject of several analyst reports. Raymond James reiterated an "outperform" rating and issued a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Bank of America upgraded Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target on the stock in a report on Friday, December 13th. KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Barclays lifted their target price on Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target on the stock. in a report on Friday, January 10th. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Revvity currently has an average rating of "Moderate Buy" and an average target price of $136.25.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.